The FDA’s recent approval of OZEMPIC highlights the expanding use of GLP-1 drugs beyond diabetes and weight management. Novo Nordisk’s blockbuster medication has gained another label expansion, now ...

A small but significant new study showed low doses of Ozempic helped people to drink less. Scientists are starting to ...

Lupin and its alliance partner Natco received clearance from the FDA for bosentan tablets for oral suspension, 32 mg, which ...

Previously only available at Walmart, the line is available at 1,400 CVS Pharmacy locations and on the retailer’s website ...

Tennessee Attorney General Jonathan Skrmetti is leading a bipartisan coalition urging the Food and Drug Administration to ...

People using semaglutide for diabetes or weight loss have also reported experiencing a reduced desire for alcohol.

Semaglutide — the active ingredient in the brand-name meds Ozempic, Wegovy, and Rybelsus — treats type 2 diabetes and obesity ...

The rise in GLP-1 drugs is undeniable. Morgan Stanley projects that by 2035, 24 million Americans, or 7% of the population, will be using these medications. But that estimate may ...

A lawsuit filed in the Singapore International Commercial Court is seeking $830 million in damages from KBP, with Novo ...

Weight loss injections have become incredibly popular in the last year or so. In fact, these medications are so widely used ...